Custom CARs: Leveraging the Adaptability of Allogeneic CAR Therapies to Address Current Challenges in Relapsed/Refractory DLBCL.
- Resource Type
- Article
- Authors
- Jeyakumar, Nikeshan; Smith, Melody
- Source
- Frontiers in Immunology; 5/18/2022, Vol. 13, p1-9, 9p
- Subject
- DIFFUSE large B-cell lymphomas
GRAFT versus host disease
KILLER cells
HEMATOPOIETIC stem cell transplantation
CHIMERIC antigen receptors
SUBSTANCE abuse relapse
- Language
- ISSN
- 16643224
Copyright of Frontiers in Immunology is the property of Frontiers Media S.A. and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)